Evoke Pharma Stock Forecast - Simple Moving Average
| EVOK Stock | USD 29.45 0.75 2.48% |
Evoke Stock outlook is based on your current time horizon. Although Evoke Pharma's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Evoke Pharma's systematic risk associated with finding meaningful patterns of Evoke Pharma fundamentals over time.
As of now The relative strength index (RSI) of Evoke Pharma's share price is above 80 suggesting that the stock is significantly overbought by investors. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 80
Buy Stretched
Oversold | Overbought |
EPS Estimate Next Quarter (0.30) | EPS Estimate Current Year (1.88) | EPS Estimate Next Year 0.68 | Wall Street Target Price 18 | EPS Estimate Current Quarter (0.45) |
Using Evoke Pharma hype-based prediction, you can estimate the value of Evoke Pharma from the perspective of Evoke Pharma response to recently generated media hype and the effects of current headlines on its competitors.
Evoke Relative Strength Index
The Simple Moving Average forecasted value of Evoke Pharma on the next trading day is expected to be 29.45 with a mean absolute deviation of 0.81 and the sum of the absolute errors of 47.64.Evoke Pharma Hype to Price Pattern
Investor biases related to Evoke Pharma's public news can be used to forecast risks associated with an investment in Evoke. The trend in average sentiment can be used to explain how an investor holding Evoke can time the market purely based on public headlines and social activities around Evoke Pharma. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Evoke Pharma's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Evoke Pharma.
The Simple Moving Average forecasted value of Evoke Pharma on the next trading day is expected to be 29.45 with a mean absolute deviation of 0.81 and the sum of the absolute errors of 47.64. Evoke Pharma after-hype prediction price | USD 29.45 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Evoke Pharma to cross-verify your projections. Evoke Pharma Additional Predictive Modules
Most predictive techniques to examine Evoke price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Evoke using various technical indicators. When you analyze Evoke charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Evoke Pharma Simple Moving Average Price Forecast For the 26th of January
Given 90 days horizon, the Simple Moving Average forecasted value of Evoke Pharma on the next trading day is expected to be 29.45 with a mean absolute deviation of 0.81, mean absolute percentage error of 4.86, and the sum of the absolute errors of 47.64.Please note that although there have been many attempts to predict Evoke Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Evoke Pharma's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Evoke Pharma Stock Forecast Pattern
| Backtest Evoke Pharma | Evoke Pharma Price Prediction | Buy or Sell Advice |
Evoke Pharma Forecasted Value
In the context of forecasting Evoke Pharma's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Evoke Pharma's downside and upside margins for the forecasting period are 6.64 and 52.26, respectively. We have considered Evoke Pharma's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Evoke Pharma stock data series using in forecasting. Note that when a statistical model is used to represent Evoke Pharma stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 116.0164 |
| Bias | Arithmetic mean of the errors | -0.6204 |
| MAD | Mean absolute deviation | 0.8075 |
| MAPE | Mean absolute percentage error | 0.0433 |
| SAE | Sum of the absolute errors | 47.645 |
Predictive Modules for Evoke Pharma
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evoke Pharma. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Evoke Pharma After-Hype Price Density Analysis
As far as predicting the price of Evoke Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Evoke Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Evoke Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Evoke Pharma Estimiated After-Hype Price Volatility
In the context of predicting Evoke Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Evoke Pharma's historical news coverage. Evoke Pharma's after-hype downside and upside margins for the prediction period are 6.64 and 52.26, respectively. We have considered Evoke Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Evoke Pharma is moderately volatile at this time. Analysis and calculation of next after-hype price of Evoke Pharma is based on 3 months time horizon.
Evoke Pharma Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Evoke Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Evoke Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Evoke Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
4.29 | 22.81 | 2.14 | 0.14 | 8 Events / Month | 2 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
29.45 | 29.45 | 0.00 |
|
Evoke Pharma Hype Timeline
Evoke Pharma is currently traded for 29.45. The entity has historical hype elasticity of -2.14, and average elasticity to hype of competition of -0.14. Evoke is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 4.29%. %. The volatility of related hype on Evoke Pharma is about 68430.0%, with the expected price after the next announcement by competition of 29.31. About 25.0% of the company shares are held by institutions such as insurance companies. The company recorded a loss per share of 1.38. Evoke Pharma had not issued any dividends in recent years. The entity had 1:12 split on the 1st of August 2024. Given the investment horizon of 90 days the next estimated press release will be in about 8 days. Check out Historical Fundamental Analysis of Evoke Pharma to cross-verify your projections.Evoke Pharma Related Hype Analysis
Having access to credible news sources related to Evoke Pharma's direct competition is more important than ever and may enhance your ability to predict Evoke Pharma's future price movements. Getting to know how Evoke Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Evoke Pharma may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| YCBD | cbdMD Inc | (0.07) | 8 per month | 7.65 | 0.02 | 19.17 | (14.07) | 112.24 | |
| BFRI | Biofrontera | (0.01) | 7 per month | 4.83 | 0.02 | 9.59 | (7.59) | 32.71 | |
| SBFM | Sunshine Biopharma | (0.06) | 7 per month | 0.00 | (0.24) | 4.73 | (5.65) | 13.93 | |
| SNOA | Sonoma Pharmaceuticals | (0.09) | 10 per month | 0.00 | (0.08) | 5.03 | (5.01) | 19.00 | |
| ADIL | Adial Pharmaceuticals | 0.00 | 0 per month | 0.00 | (0.18) | 5.56 | (6.25) | 16.67 | |
| MHUA | Meihua International Medical | 0.00 | 0 per month | 0.00 | (0.07) | 22.64 | (25.45) | 60.20 | |
| NRSN | Neurosense Therapeutics | 0.00 | 0 per month | 0.00 | (0.03) | 12.82 | (7.48) | 34.62 | |
| SSKN | STRATA Skin Sciences | (0.07) | 2 per month | 0.00 | (0.09) | 7.56 | (7.30) | 25.41 | |
| BMRA | Biomerica | 0.00 | 0 per month | 0.00 | (0.07) | 4.12 | (4.98) | 18.44 |
Other Forecasting Options for Evoke Pharma
For every potential investor in Evoke, whether a beginner or expert, Evoke Pharma's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Evoke Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Evoke. Basic forecasting techniques help filter out the noise by identifying Evoke Pharma's price trends.Evoke Pharma Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evoke Pharma stock to make a market-neutral strategy. Peer analysis of Evoke Pharma could also be used in its relative valuation, which is a method of valuing Evoke Pharma by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Evoke Pharma Market Strength Events
Market strength indicators help investors to evaluate how Evoke Pharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evoke Pharma shares will generate the highest return on investment. By undertsting and applying Evoke Pharma stock market strength indicators, traders can identify Evoke Pharma entry and exit signals to maximize returns.
Evoke Pharma Risk Indicators
The analysis of Evoke Pharma's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Evoke Pharma's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting evoke stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 8.16 | |||
| Semi Deviation | 0.9107 | |||
| Standard Deviation | 22.13 | |||
| Variance | 489.55 | |||
| Downside Variance | 11.31 | |||
| Semi Variance | 0.8293 | |||
| Expected Short fall | (9.05) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Evoke Pharma
The number of cover stories for Evoke Pharma depends on current market conditions and Evoke Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Evoke Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Evoke Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Evoke Pharma Short Properties
Evoke Pharma's future price predictability will typically decrease when Evoke Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Evoke Pharma often depends not only on the future outlook of the potential Evoke Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Evoke Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.9 M | |
| Cash And Short Term Investments | 13.6 M |
Check out Historical Fundamental Analysis of Evoke Pharma to cross-verify your projections. For more information on how to buy Evoke Stock please use our How to buy in Evoke Stock guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Evoke Pharma. If investors know Evoke will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Evoke Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.38) | Revenue Per Share | Quarterly Revenue Growth 0.614 | Return On Assets | Return On Equity |
The market value of Evoke Pharma is measured differently than its book value, which is the value of Evoke that is recorded on the company's balance sheet. Investors also form their own opinion of Evoke Pharma's value that differs from its market value or its book value, called intrinsic value, which is Evoke Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Evoke Pharma's market value can be influenced by many factors that don't directly affect Evoke Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Evoke Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Evoke Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Evoke Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.